Role of the KCa3.1 K+ channel in auricular lymph node CD4+ T-lymphocyte function of the delayed-type hypersensitivity model

British Journal of Pharmacology

Volumn 169, Issue 5, 2013, Pages 1011-1023

  Ohya, Susumu ^a,b   Nakamura, Erina ^a   Horiba, Sayuri ^a   Kito, Hiroaki ^a   Matsui, Miki ^a   Yamamura, Hisao ^a   Imaizumi, Yuji ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

auricular lymph node; CD4+ T lymphocyte; delayed type hypersensitivity; intermediate conductance Ca2+ activated K+ channel; repressor element 1 silencing transcription factor; TRAM 34

Indexed keywords

1 [(2 CHLOROPHENYL)DIPHENYLMETHYL] 1H PYRAZOLE; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; POTASSIUM CHANNEL KCA3.1A; UNCLASSIFIED DRUG; IMMUNOLOGICAL ADJUVANT; KCNN4 PROTEIN, MOUSE; OXAZOLONE; POTASSIUM CHANNEL BLOCKING AGENT; PYRAZOLE DERIVATIVE; RE1-SILENCING TRANSCRIPTION FACTOR; REPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FLOW CYTOMETRY; IMMUNOPATHOGENESIS; LYMPHOCYTE FUNCTION; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL CYCLE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; EXTERNAL EAR; IMMUNOLOGY; LYMPH NODE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; DISEASE MODELS, ANIMAL; EAR AURICLE; HYPERSENSITIVITY, DELAYED; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; LYMPH NODES; MALE; MICE, INBRED BALB C; OXAZOLONE; POTASSIUM CHANNEL BLOCKERS; PYRAZOLES; REPRESSOR PROTEINS;

EID: 84879006480     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12215     Document Type: Article

References (52)

1. Ahlfors EE, Lyberg T, (2010). Kinetics of local tissue and regional lymph node IL-2 and IFN-γ responses in experimental oral mucosa and skin contact sensitivity in mice. Scand J Immunol 72: 8-14.
2. 2+ stores, phosphorylation of eIF2alpha, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole. Proc Natl Acad Sci U S A 95: 8280-8285.
3. Azam P, Sankaranarayanan A, Homerick D, Griffey S, Hulff H, (2007). Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis. J Invest Dermatol 127: 1419-1429.
4. Becchetti A, (2011). Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer. Am J Physiol Cell Physiol 301: C255-C265.
5. Beeton C, Chandy KG, (2005). Potassium channels, memory T cells, and multiple sclerosis. Neuroscientist 11: 550-562.
6. + channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci U S A 98: 13942-13947.
7. Cahalan MD, Chandy KG, (2009). The functional network of ion channels in T lymphocytes. Immunol Rev 231: 59-87.
8. + channels as targets for specific immunomodulation. Trends Pharmacol Sci 25: 280-289.
9. Ca2.3 channel-dependent hyperpolarization increases melanoma cell motility. Exp Cell Res 315: 3620-3630.
10. Cheong A, Bingham AJ, Li J, Kumar B, Sukumar P, Munsch C, et al. (2005). Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell proliferation. Mol Cell 20: 45-52.
11. Chipinda I, Anderson SE, Butterworth LF, Beezhold D, Siegel PD, (2009). Increased cell proliferation in spleen and lymph nodes peripheral to contact allergen application site. Toxicology 257: 113-116.
12. Chou CC, Lunn CA, Murgolo NJ, (2008). KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation. Expert Rev Mol Diagn 8: 179-187.
13. 0 T cells. Cytometry 14: 883-890.
14. + channels are required for human lung mast cell migration. Thorax 61: 880-885.
15. Ca3.1 ameliorates T cell-mediated colitis. Proc Natl Acad Sci U S A 107: 1541-1546.
16. Ca3.1, resulting in defective T cell activation. J Biol Chem 285: 38765-38771.
17. Evans DP, Hossack M, Thomson DS, (1971). Inhibition of contact sensitivity in the mouse by topical application of corticosteroids. Br J Pharmacol 43: 403-408.
18. Funabashi K, Fujii M, Yamamura H, Ohya S, Imaizumi Y, (2010). Contribution of chloride channel conductance to the regulation of resting membrane potential in chondrocyte. J Pharmacol Sci 113: 94-99.
19. Ca1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 275: 37137-37149.
20. + T cells. Nature 477: 216-219.
21. Gocke AR, Lebson LA, Grishkan IV, Nguyen HM, Whartenby KA, Chandy KG, et al. (2012). Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistance to autoimmune encephalomyelitis. J Immunol 188: 5877-5886.
22. Gopalakrishnan V, (2009). REST and RESTless: in stem cells and beyond. Future Neurol 4: 317-329.
23. Ca3.1) in mice causes subtle erythrocyte macrocytosis and progressive splenomegaly. Pflügers Arch 458: 291-302.
24. Ca3.1 potassium channels. Proc Natl Acad Sci U S A 106: 14518-14523.
25. Iskar M, Campillos M, Kuhn M, Jensen LJ, Noort VV, Bork P, (2010). Drug-induced regulation of target expression. PLoS Comput Biol 9: e1000925.
26. + channel of intermediate conductance: a molecular target for novel treatments? Curr Drug Targets 2: 401-422.
27. Jochum W, Passegue E, Wagner EF, (2001). AP-1 in mouse development and tumorigenesis. Oncogene 20: 2401-2412.
28. Köhler R, Wulff H, Eichler I, Kneifel M, Neumann D, Knorr S, et al. (2003). Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 108: 1119-1125.
29. Lioa P, Ahang HY, Soong TW, (2009). Alternative splicing of voltage-gated calcium channels: from molecular biology to disease. Pflügers Arch 458: 481-487.
30. Lu TX, Hartner J, Lim EJ, Fabry V, Mingler MK, Cole ET, et al. (2011). MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol 187: 3362-3373.
31. V1.3 channel block. Immunity 29: 602-614.
32. + channel SK2. J Neurochem 106: 2312-2321.
33. Ca3.1 compartmentalizes in the immunological synapse of human T lymphocytes. Am Physiol Cell Physiol 292: C1431-C1439.
34. + channels in cardiac mitochondria. Am J Physiol Heart Circ Physiol 289: H1635-H1642.
35. Ca3.1, as a novel therapeutic target of benign prostatic hyperplasia. J Pharmacol Exp Ther 338: 528-536.
36. Ca3.1 in lymphoid cells. J Biol Chem 286: 16940-16952.
37. V1.3 and IK-1 as immunosuppressants. Bioorg Med Chem Lett 19: 2299-2304.
38. Pennington MW, Beeton C, Galea CA, Smith BJ, Chi V, Monaghan KP, et al. (2009). Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes. Mol Pharmacol 75: 762-773.
39. + channels regulate human airway smooth muscle proliferation. Am J Respir Cell Mol Biol 37: 525-531.
40. Ca3.1. Mol Cell Biol 25: 3630-3638.
41. Ca3.1 and CD4 T cells. Mol Cell 24: 665-675.
42. Ca3.1. Proc Natl Acad Sci U S A 105: 14442-14446.
43. Ca3.1 and CD4 T-cells. Mol Biol 20: 3783-3791.
44. Tarcha EJ, Chi V, Muñoz-Elías EJ, Bailey D, Londono LM, Upadhyay SK, et al. (2012). Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease. J Pharmacol Exp Ther 342: 642-653.
45. Ca1) mediates phenotypic modulation of coronary smooth muscles. Am J Physiol Heart Circ Physiol 291: H2493-H2503.
46. Ca3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis. Arterioscler Thromb Vasc Biol 28: 1084-1089.
47. Varga Z, Gurrola-Briones G, Papp F, Rodríguez de la Vega RC, Pedraza-Alva G, Tajhya RB, et al. (2012). Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells. Mol Pharmacol 82: 372-382.
48. + T-cell migration into inflamed skin and its inhibition by CCR4/CCR10 blockades using in vivo imaging model. Br J Dermatol 162: 487-496.
49. + channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A 97: 8151-8156.
50. + channel in the promotion of cell proliferation by ATP in brain endothelial cells. J Biol Chem 281: 38430-38439.
51. Zhang W, Ramamoorthy Y, Lilicarslan T, Nolte H, Tydale RF, Sellers EM, (2002). Inhibition of cytochromes P450 by antifungal imidazole derivatives. Drug Metab Dispos 30: 214-318.
52. Zhang XH, Zhang YY, Sun HY, Jin MW, Li GR, (2012). Functional ion channels and cell proliferation in 3T3-L1 preadipocytes. J Cell Physiol 227: 1972-1979.